While K-ras Is Essential for Mouse Development, Expression of the K-ras 4A Splice Variant Is Dispensable

Molecular and Cellular Biology

Volumn 23, Issue 24, 2003, Pages 9245-9250

  Plowman, Sarah J ^a   Williamson, D James ^b,d   O'Sullivan, Maureen J ^b   Doig, Jennifer ^a   Ritchie, Ann Marie ^a   Harrison, David J ^b   Melton, David W ^a   Arends, Mark J ^c   Hooper, Martin L ^a   Patek, Charles E ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CECUM; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC CODE; GENETIC VARIABILITY; HISTOPATHOLOGY; INBRED STRAIN; INHERITANCE; LUNG; MALE; MATING; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE K RAS 4A; PANCREAS; PRIORITY JOURNAL; REGULATORY MECHANISM; SALIVARY GLAND; SEMINAL VESICLE; UTERUS;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; DNA; FEMALE; FERTILITY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, RAS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PROTEIN ISOFORMS; TISSUE DISTRIBUTION;

ANIMALIA; MAMMALIA;

EID: 10744231278     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.24.9245-9250.2003     Document Type: Article

References (32)

1. Adjei, A. A. 2001. Blocking oncogenic Ras signalling for cancer therapy. J. Natl. Cancer Inst. 93:1062-1074.
2. Ahmadian, M. R. 2002. Prospects for anti-ras drugs. Br. J. Hematol. 116: 511-518.
3. Apolloni, A. I., A. Prior, M. Lindsay, R. G. Parton, and J. F. Hancock. 2000. H-Ras but not K-Ras traffics to the plasma membrane through the exocytic pathway. Mol. Cell. Biol. 20:2475-2487.
4. Brooks, D. J., R. M. James, C. E. Patek, J. Williamson, and M. J. Arends. 2001. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19 (ARF). Oncogene 20:2144-2152.
5. Capon, D. J., P. H. Seeburg, J. P. McGrath, J. S. Hayflick, U. Edman, A. D. Levinson, and D. V. Goeddel. 1983. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507-513.
6. de Castro, I. P., R. Diaz, M. Malumbres, M-I. Hernandez, J. Jagirdar, M. Jimenez, D. Ahn, and A. Pellicer. 2003. Mice deficient for N-ras: Impaired antiviral immune response and T-cell function. Cancer Res. 63:1615-1622.
7. Diaz, R., D. Ahn, L. Lopez-Barcons, M. Malumbres, I. P. de Castro, J. Lue, N. Ferrer-Miralles, R., Mangues, J. Tsong, R. Garcia, R. Perez-Soler, and A. Pellicer. 2002. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res. 62:4514-4518.
8. Ehrhardt, A., G. R. A. Ehrhardt, X. Guo, and J. W. Schrader. 2002. Ras and relatives-job sharing and networking keep an old family together. Exp. Hematol. 30:1089-1106.
9. Ellis, C. A., and G. Clark. 2000. The importance of being K-Ras. Cell. Signalling 12:425-434.
10. Esteban, L. M., C. Vicario-Abejon, P. Fernandez-Salguero, A. Fernandez-Medarde, N. Swaminathan, K. Yienger, E. Lopez, M. Malumbres, R. McKay, J. M. Ward, A. Pellicer, and E. Santos. 2001. Targeted disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21:1444-1452.
11. Fan, J., and J. R. Bertino. 1997. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene 14:2595-2607.
12. Fisher, G. H., S. L. Wellen, D. Klimstra, J. M. Lenczowski, J. W. Tichelaar, M. J. Lizak, J. A. Whitsett, A. Koretsky, and H. E. Varmus. 2001. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumour suppressor genes. Genes Dev. 15:3249-3262.
13. George, D. L., A. F. Scott, S. Trusko, B. Glick, E. Ford, and D. J. Dorney. 1985. Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumour cells. EMBO J. 4:1199-1203.
14. Hancock, J. F. 2003. Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell. Biol. 4:273-284.
15. Ise, K., K. Nakamura, K. Nakao, S. Shimizu, H. Harada, T. Ichise, J. Miyoshi, Y. Gondo, T. Ishikawa, A. Aiba, and M. Katsuki. 2000. Targeted deletion of the H-ras gene decreases tumour formation in mouse skin carcinogenesis. Oncogene 19:2951-2956.
16. Jackson, J. H., J. W. Li, J. E. Buss, C. J. Der, and C. G. Cochrane. 1994. Polylysine domain of K-ras 4B protein is crucial for malignant transformation. Proc. Natl. Acad. Sci. 91:12730-12734.
17. Janssen, K. P., F. el Marjou, D. Pinto, X. Sastre, D. Rouillard, C. Fouquet, T. Soussi, D. Louvard, and S. Robine. 2002. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123:492-504.
18. Johnson, L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R. T. Bronson, H. Umanoff, W. Edelmann, R. Kucherlapati, and T. Jacks. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:2468-2481.
19. Koera, K., K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, T. Hatta, H. Otani, A. Aiba, and M. Katsuki. 1997. K-ras is essential for the development of the mouse embryo. Oncogene 15:1151-1159.
20. Magin, T. W., J. McWhir, and D. W. Melton. 1992. A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucleic Acids Res. 20:3795-3796.
21. McGrath, J. P., D. J. Capon, D. H. Smith, E. Y. Chen, P. H. Seeburg, D. V. Goeddel, and A. D. Levinson. 1983. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature 304:501-506.
22. Pells, S., M. Divjak, P. Romanowski, H. Impey, N. J. Hawkins, A. R. Clarke, M. L. Hooper, and D. J. Williamson. 1997. Developmentally regulated expression of murine K-ras isoforms. Oncogene 15:1781-1786.
23. Prior, I. A., A. Harding, J. Yan, J. Sluimer, R. G. Parton, and J. F. Hancock. 2001. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell. Biol. 3:368-375.
24. Roy, S., R. Luetterforst, A. Harding, A. Apolloni, M. Etheridge, E. Stang, B. Rolls, J. F. Hancock, and R. G. Parton. 1999. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell. Biol. 1:98-105.
25. Silvius, J. R. 2002. Mechanisms of Ras protein targeting in mammalian cells. J. Membrane Biol. 190:83-92.
26. Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. 92:1709-1713.
27. Vikis, H. G., S. Stewart, and K. L. Guan. 2002. SmgGDS displays differential binding and exchange activity towards different Ras isoforms. Oncogene 21:2425-2432.
28. Voice, J. K., R. L. Klemke, A. Le, and J. H. Jackson. 1999. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274:17164-17170.
29. Walsh, A. B., and D. Bar-Sagi. 2001. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem. 276:15609-15615.
30. Wang, Y., M. You, and Y. Wang. 2001. Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp. Lung Res. 27:255-267.
31. Yan, J., S. Roy, A. Apolloni, A. Lane, and J. F. Hancock. 1998. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273:24052-24056.
32. Zhang, Z., Y. Wang, H. G. Vikis, L. Johnson, G. Liu, J. Li, M. W. Anderson, R. C. Sills, H. L. Hong, T. R. Devereux, T. Jacks, K-L. Guan, and M. You. 2001. Wild-type Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29:25-33.